GSK:NYSE
GSK plc
47,02 US$
arrow_upward
+0,90%(+0,42) 1D
46,43 US$
arrow_downward
-1,25% (-0,59)todayPre-market
Closed: 7 ოქტ, 16:00:02 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GSK...
Open
46,92 US$
High
47,40 US$
Low
46,69 US$
Mkt. cap
95,26 მლრდ.
Avg. vol.
3,41 მლნ.
Volume
34,35 ათ.
Dividend
3,86%
Quarterly dividend
0,45 US$
Ex-dividend date
13 აგვ. 2026
P/E ratio
15,01
52-wk high
61,70 US$
52-wk low
42,84 US$
EPS
3,13 US$
Beta
0,25
Shares outstanding
2,02 მლრდ.
No. of employees
67 ათ.
Open
46,92 US$
High
47,40 US$
Low
46,69 US$
Mkt. cap
95,26 მლრდ.
Avg. vol.
3,41 მლნ.
Volume
34,35 ათ.
Dividend
3,86%
Quarterly dividend
0,45 US$
Ex-dividend date
13 აგვ. 2026
P/E ratio
15,01
52-wk high
61,70 US$
52-wk low
42,84 US$
EPS
3,13 US$
Beta
0,25
Shares outstanding
2,02 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
Analytics Insight
·
1 საათის წინ
AstraZeneca vs GSK: Comparing Two UK Stocks in AI-Driven Healthcare
JournalArta
·
8 საათის წინ
Momentum Weakens, GSK Stock Gains 1.42%: What to Know
AD HOC NEWS
·
22 საათის წინ
GSK stock adds a liver candidate to its pipeline
Traders Union
·
1 დღის წინ
GSK shares technical analysis: Resistance test at GBX1,769 limits rebound
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEOემა უოლმსლი | ემა უოლმსლი
Employees66,8 ათ.
Founded27 დეკ. 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com